2nd Quarter - Report

MASTERCARD WORLDWIDE for MASTERCARD WORLDWIDE

Firm
Client
Income
—
Expenses
$840,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Banking BAN

Issues related to the regulation of consumer financial products, including S. 566 (the Financial Product Safety Commission Act) and H.R. 1705 (companion legislation to S. 566); Issues involving payment cards, interchange fees, and card issuer practices, including H.R. 2382 (the Credit Card Interchange Fees Act), H.R. 2695 (the Credit Card Fair Fee Act), S. 1212 (the Credit Card Fair Fee Act), S. 414 (the Credit Card Accountability Responsibility and Disclosure Act), H.R. 627 (the Credit Cardholders Bill of Rights Act), S. 325 (the Credit Cardholders Bill of Rights Act), S. 392 (the Credit Card Reform Act), S. 399 (the Universal Default Prohibition Act), H.R. 1456 (the Consumer Overdraft Protection Fair Practices Act), H.R. 1608 (the Protecting Consumers from Unreasonable Credit Rates Act) and S. 500 (companion legislation to H.R. 1608), H.R. 1610 (the Interest Rate Equity Act), H.R. 2007 (the American Credit Card Reform Act), S. 710 (the Fair Gift Card Act), S. 165 (the Student Credit Card Protection Act), S. 900 (the Credit Card Safety Star Act), and provisions in H.R. 3170 (the Financial Services and General Government Appropriations Act); Issues pertaining to data security, security breach notification, and mitigation of harm resulting from security breaches, including H.R. 2221 (the Data Accountability and Trust Act), S. 139 (the Data Breach Notification Act), and S. 1070 (a bill to establish the Small Business Information Security Task Force); Issues involving the bankruptcy code, including S. 257 (the Consumer Credit Fairness Act); Issues related to federal agency enforcement authority, including H.R. 2309 (the Consumer Credit and Debt Protection Act); and market access issues in global markets. Issues related to the use of payment cards in connection with the purchase of prescription medications over the Internet, including provisions in S. 525 (the Pharmaceutical Market Access and Drug Safety Act) and H.R. 1298 (companion legislation to S. 525); Issues related to the regulation of Internet gambling, including H.R. 2266 (the Reasonable Prudence in Regulation Act), H.R. 2267 (the Internet Gambling Regulation, Consumer Protection, and Enforcement Act), and H.R. 2268 (the Internet Gambling Regulation and Tax Enforcement Act);

LobbyistCovered position, as disclosed
TUCKER FOOTE —
RICHARD SCOTT SILVERTHORNE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1608 (111th), S. 325 (111th), H.R. 1298 (111th), H.R. 2382 (111th), S. 165 (111th), S. 525 (111th), H.R. 627 (111th), S. 566 (111th), H.R. 2221 (111th), H.R. 1456 (111th), H.R. 2267 (111th), S. 1070 (111th), S. 500 (111th), S. 414 (111th), S. 392 (111th), H.R. 1705 (111th), H.R. 2266 (111th), S. 139 (111th), S. 1212 (111th), H.R. 3170 (111th), H.R. 1610 (111th), H.R. 2695 (111th), S. 257 (111th), S. 710 (111th), H.R. 2007 (111th), S. 399 (111th), H.R. 2309 (111th), S. 900 (111th), H.R. 2268 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.